Clinical Trials Browser

Phase 1/2 × HER-2 Positive Colorectal Cancer × pyrotinib × Clear all

NCT04227041 2020-01-14

A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

HER-2 Positive Colorectal Cancer